Torrent Pharmaceuticals
Search results
An Indian multinational pharmaceuticals company that provides high quality, affordable and innovative solutions in medicine and treatment.
Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in Ahmedabad. The company's operations focus on manufacturing products ranging from active pharmaceutical intermediates, finished formulations, food supplements, biotechnology products and pharmaceutical machinery.
World’s First Innovation. R&D Chronicles. Our care continuum is an unending chain, connecting one person to another, leading to optimum health outcomes for all.
Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over the past six decades, we have been developing and manufacturing affordable medicines for patients around the world.
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, [3] is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs.
Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited), a leading Indian Pharmaceutical company is a fully integrated, global healthcare provider.
Founded by Shri I.A. Modi, Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the State of Gujarat.
Cadila Pharmaceuticals Limited operates as a pharmaceutical firm. The Company develops and manufactures pharmaceutical products and generic formulations for treatment of cardiovascular ...
Feb 28, 1991 · Cadila Pharmaceuticals Limited is a Non-govt company, incorporated on 28 Feb, 1991. It's a public unlisted company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 12065.0 lakhs and has 99.79451% paid-up capital which is Rs 12040.21 lakhs.
Find company research, competitor information, contact details & financial data for CADILA PHARMACEUTICALS LIMITED of Ahmedabad, Gujarat. Get the latest business insights from Dun & Bradstreet.
